PSC-Derived Cartilage Tissue Under Hypoxic 3D Pellet Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for repairing articular cartilage defects, such as autologous chondrocyte implantation and bone marrow stimulation, are limited by invasive procedures, low cell harvestability, and inferior cartilage quality, while 3D cartilage constructs face challenges in consistent clinical outcomes and immunoprivileged characteristics.
Innovation Solution
A method for producing chondrocytes and cartilage tissue using pluripotent stem cells (PSCs) through a multi-step differentiation process involving hypoxic conditions and specific growth factors like WNT, Activin, FGF, BMP, Neurotrophin, and GDF, culminating in the formation of hyaline-like cartilage tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If autologous chondrocyte implantation is used to repair cartilage defects, then cartilage repair is achieved, but invasive surgery is required and limited number of cells can be harvested
Solution Approach 1:
The patent uses pluripotent stem cells as a disposable, renewable cell source that can be differentiated into chondrocytes in vitro, eliminating the need for invasive autologous cartilage harvesting while providing sufficient cell numbers for repair
2Quantity of substance
If bone marrow-derived stem cells are used for cartilage repair, then cell availability is improved, but invasive procedures are required and immunoprivileged characteristics are lost
Solution Approach 1:
The patent employs pluripotent stem cells that can be expanded and differentiated in vitro to provide sufficient chondrocytes for repair, eliminating the need for invasive bone marrow procedures while maintaining immunoprivileged characteristics through controlled differentiation protocols
3Quantity of substance
If chondrocytes are expanded in monolayer cultures to increase cell number, then cell availability is improved, but de-differentiation occurs and cartilage quality deteriorates
Solution Approach 1:
The patent transitions from 2D monolayer culture to 3D pellet culture system, allowing chondrocytes to maintain their phenotypic characteristics while proliferating. The 3D environment provides appropriate mechanical and biochemical cues that preserve chondrocyte differentiation state
Solution Approach 2:
The patent modifies culture parameters including oxygen tension (hypoxic conditions), growth factor composition (TGF-β, BMPs), and matrix composition to maintain chondrocyte phenotype during expansion. These parameter changes prevent de-differentiation while enabling sufficient cell proliferation
4Shape
If scaffold-based approaches are used to create 3D cartilage constructs, then cartilage structure is improved, but immunoprivileged characteristics are compromised and clinical outcomes remain inconsistent
Solution Approach 1:
The patent extracts and eliminates the scaffold component from tissue engineering approaches, using scaffold-free 3D pellet cultures of pluripotent stem cell-derived chondrocytes. This removal of foreign scaffold material eliminates associated immunogenicity while maintaining 3D cartilage structure formation
Solution Approach 2:
The patent uses temporary, biodegradable extracellular matrix components produced by the chondrocytes themselves rather than permanent synthetic scaffolds, reducing immunogenicity and improving clinical consistency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method reproducibly produces healthy, non-necrotic chondrocytes and 3D cartilage tissue that closely resembles native hyaline cartilage, overcoming limitations of existing therapies by maintaining pluripotent characteristics and improving cartilage quality.
Implementation Method 1
inducing differentiation of the PSCs into a primitive streak/mesendoderm by culturing the PSCs in hypoxic conditions
Implementation Method 2
in a (mesendodermic) culture media comprising: i) a Wingless/Integrated (WNT) family member, ii) an Activin family member, and iii) a Fibroblast Growth Factor (FGF) family member
Implementation Method 3
forming a pellet of the chondrocytes and culturing the pellet of the chondrocytes in a culture media under hypoxic conditions to produce the cartilage
Data Source
AI summary
The invention relates to a method for producing cartilage from pluripotent stem cells (PSCs), the method comprising providing chondrocytes by: 1) providing pluripotent stem cells (PSCs); 2) inducing differentiation of the PSCs into a primitive streak/mesendoderm by culturing the PSCs in hypoxic conditions, in a (mesendodermic) culture media comprising: i) a Wingless/Integrated (WNT) family member, ii) an Activin family member, and iii) a Fibroblast Growth Factor (FGF) family member; 3) inducing differentiation of the primitive streak/mesendoderm into a mesoderm by culturing the primitive streak/mesendoderm in hypoxic conditions, in a (mesodermic) culture media comprising: i) a FGF family member, ii) a bone morphogenetic protein (BMP) family member, iii) Follistatin, and iv) a Neurotrophin (NT); and 4) inducing differentiation of the mesoderm into chondrocytes by culturing the mesoderm in hypoxic conditions, in a (chondroinductive) culture media comprising: i) a FGF family member, ii) a BMP family member, iii) a Neurotrophin, and iv) a Growth/Differentiation Factor (GDF) family member; and forming a pellet of the chondrocytes and culturing the pellet of the chondrocytes in a culture media under hypoxic conditions to produce the cartilage. The invention further relates to methods of chondrocyte production, synthetically produced cartilage, and use in therapy.